Resource Article: Allergen Barrier Testing: Ensuring Accurate Claims in Textile Labelling

Why Thread Count Is the Wrong Measure for Allergen Barrier Performance

The debate over thread count inflation has been ongoing for years. In a 2011 article in Home Textile Today, Editor-in-Chief Jennifer Marks highlighted the growing confusion around thread count and its diminishing relevance as a meaningful performance indicator. Yet despite this, it remains the most commonly cited proxy for allergen barrier efficacy on retail packaging.

The assumption — that higher thread counts produce smaller pores and therefore better allergen blocking — is not scientifically accurate. Thread count describes the number of threads per square inch of fabric. It says nothing meaningful about pore size, allergen filtration efficiency, or the complex physical and chemical interactions that determine whether an allergen passes through a textile.

Pore size measurement: limitations of the bubble point method

Pore size is most commonly measured using the bubble point method — a technique that is quick and relatively inexpensive, but has well-documented limitations. It cannot account for unopened pores, and results vary significantly depending on fabric construction and pre-treatment. More precise methods, including scanning and projection microscopy, provide detailed structural imagery of warp and weft that consistently exposes high thread count claims offering no measurable reduction in functional pore size.

Even pore size alone is an incomplete predictor of allergen filtration efficacy. Two additional factors significantly influence whether an allergen passes through a textile:

• Van der Waals forces — electrostatic attraction between allergen particles and fabric fibres can cause allergens to adhere to or repel from textile surfaces independently of pore geometry.
• Allergen conformation — the three-dimensional shape of allergen particles affects how they interact with textile structure during airflow, meaning two allergens of nominally similar size can behave very differently in filtration conditions.

What an Effective Allergen Barrier Must Actually Block

Any textile making allergen barrier claims must be evaluated against the specific allergens it purports to block. The three most clinically significant categories for bedding are:

Traditional glass bead filtration methodologies — historically used in military filter evaluations — have been applied to textile testing but are not reliable predictors of allergen behaviour. Glass beads do not replicate the aerodynamic and electrostatic properties of biological allergens, and results from these methods should not be used to substantiate allergen barrier claims on consumer products.

The Gold Standard: Direct Allergen Filtration Testing

How direct allergen filtration testing works

The methodology works as follows: a dust sample containing a known, measured quantity of allergen is drawn across the test textile under controlled airflow conditions. A downstream filter captures any allergen particles that pass through the fabric. These are then extracted and quantified using ELISA kits specific to the target allergen — the same immunological assay technology used in clinical diagnostic testing.

The result is a precise, reproducible measurement of allergen filtration efficiency expressed as a percentage — a number that can be directly referenced in marketing claims, technical documentation, and regulatory submissions. This is what gives manufacturers and retailers a defensible evidential basis that generic pore size measurements cannot provide.

Simulated Use Testing: Evaluating Real-World Conditions

Static filtration testing establishes baseline allergen barrier performance. But consumer textiles are not used in static conditions — they are slept on, washed, compressed and stretched repeatedly across their useful life. Simulated Use Testing addresses this by mimicking real consumer interactions with bedding and textile products.

This methodology evaluates how allergen barrier performance changes after repeated laundering cycles, mechanical stress, and extended use — factors that can significantly degrade pore structure and filtration efficiency in fabrics that perform well under initial testing. For manufacturers making durability claims, or retailers specifying minimum wash cycles on pack, Simulated Use Testing provides the evidence base to support those claims.

Together, direct allergen filtration testing and Simulated Use Testing form a comprehensive evaluation framework — one that covers both initial performance and sustained efficacy across a product’s commercial lifespan.

Airmid Healthgroup’s Role in Allergen Barrier Testing

What Retailers and Manufacturers Should Require

The ongoing confusion between thread count, pore size, and allergen filtration has created a market where misleading claims persist — not always through deliberate intent, but through reliance on insufficient test methods. As regulatory and litigation pressure increases on health-adjacent product categories, the gap between claims that can be defended and claims that cannot is becoming commercially significant.

Retailers setting supplier requirements should specify direct allergen filtration testing as the minimum standard for any allergen barrier claim. Manufacturers seeking certification should ensure their test methodology produces allergen-specific, quantified filtration data — not pore size proxies. And for both parties, independent third-party testing provides the evidentiary foundation that in-house or supplier-provided data cannot.

The standard for allergen barrier claims is direct, quantified, independently verified filtration data. Anything less is a liability.